Active Ingredient History

  • Now
Atagabalin (PD-0200,390) is a drug developed by Pfizer and related to gabapentin, which similarly binds to the α2δ calcium channels. It was under development as a treatment for insomnia, but was discontinued following unsatisfactory trial results.   Wikipedia

  • SMILES: C[C@H]1CC(CN)(CC(=O)O)C[C@@H]1C
  • Mol. Mass: 185.27
  • ALogP: 1.47
  • ChEMBL Molecule:
More Chemistry
(1-aminomethyl-3,4-dimethylcyclopentyl)acetic acid | atagabalin | pd0200390 | pd 0200390 | pd-0200390


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue